Issues with wound healing may play a central role in driving severe forms of epidermolysis bullosa (EB), a new…
Articles by Marisa Wexler, MS
A never-before-reported mutation in the KRT14 gene caused epidermolysis bullosa simplex (EBS) in a family in China. The new…
Onconova Therapeutics and Pangea Biomed are teaming up to identify biomarkers that can help predict a response to the experimental…
People with epidermolysis bullosa acquisita (EBA) are at a higher risk of developing other autoimmune disorders, certain types of…
Tofacitinib, a therapy approved for certain inflammatory diseases effectively controlled symptoms of epidermolysis bullosa acquisita (EBA) in a man with…
Topical morphine gel can help to ease pain related to wounds in people with epidermolysis bullosa (EB), a new…
Blocking the activity of an immune cell receptor protein called FcyRIV prevented the development of epidermolysis bullosa acquisita in…
The effect of epidermolysis bullosa (EB) on oral health significantly affects the quality of life of children living with…
Filsuvez (Oleogel-S10) has been approved in Great Britain — England, Scotland and Wales — for treating wounds associated with…
People with dystrophic epidermolysis bullosa (DEB) saw the total surface of their wounds significantly reduced after being treated with…
Skin tumors called cutaneous squamous cell carcinomas (cSCCs) are common in people with certain types of epidermolysis bullosa…
Treatment with the experimental protein replacement therapy PTR-01 promoted wound healing and decreased pain in people with recessive dystrophic epidermolysis…